Chemistry:Colforsin daropate

From HandWiki
Short description: Chemical compound

Colforsin daropate
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC27H43NO8
Molar mass509.640 g·mol−1
3D model (JSmol)
 ☒NcheckY (what is this?)  (verify)

Colforsin daropate is a cardiovascular drug used to treat acute heart failure.[1] Chemically, it is a carboxylic ester derived from the condensation of forskolin (colforsin) with N,N-dimethyl-β-alanine.[2]

Its water-soluble hydrochloride salt (NKH 477)[3] is an adenylyl cyclase activator which has been studied for its cardiac selectivity.[4][5]

Colforsin daropate has been studied for its potential to be repurposed for the treatment of some types of cancer.[6]

References

  1. "Colforsin daropate". AdisInsight. https://adisinsight.springer.com/drugs/800001302. 
  2. "colforsin daropate". EMBL-EBI. https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:166826. 
  3. "β-Alanine, N,N-dimethyl-, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-bpyran-6-yl ester, hydrochloride (1:1)"]. American Chemical Society. https://commonchemistry.cas.org/detail?cas_rn=138605-00-2. 
  4. "Effect of NKH477, a new water-soluble forskolin derivative, on arterial-ventricular coupling and mechanical energy transduction in patients with left ventricular systolic dysfunction: comparison with dobutamine". Journal of Cardiovascular Pharmacology 24 (2): 310–316. August 1994. doi:10.1097/00005344-199424020-00018. PMID 7526066. 
  5. "Effects of NKH477, a water-soluble forskolin derivative, on cardiac function in rats with chronic heart failure after myocardial infarction". The Journal of Pharmacology and Experimental Therapeutics 274 (1): 120–126. July 1995. doi:10.1016/S0022-3565(25)10521-1. PMID 7616388. 
  6. "Repurposing colforsin daropate to treat MYC-driven high-grade serous ovarian carcinomas". Science Signaling 17 (863). November 2024. doi:10.1126/scisignal.ado8303. PMID 39561220.